The GPER/EGFR/ERK axis is further responsible for blocking cell cycle progression, promoting apoptosis, and inhibiting cell growth in HCC cells, finally leading to reduced tumor viability both in vitro and in vivo (Figure 7). This evidence concerns the gene EGFR and hepatocellular carcinoma.